Created in 2013, Caresyntax is on a mission to make surgery smarter and safer. It operates the leading vendor-neutral, enterprise-grade software platform for collecting, tracking, and analyzing surgical procedures. This real world evidence can be used by a patient’s care team during a procedure and accessed by those outside the operating room via the platform’s dedicated telehealth link. After an intervention, the Caresyntax platform also provides insights that help surgeons benchmark and improve their care. The technology enables hospital administrators to use surgical resources more efficiently, medical device companies to generate real-world evidence, and insurance companies to understand risk and devise more tailored policies.
Caresyntax was founded in Berlin, but also has significant presences in Boston and Chicago. The company has operations worldwide with a strong footprint in France and Germany. For example, the University Hospital of Strasbourg in France is a leading customer, using the Caresyntax platform to enrich orthopedic training, improve surgeon scores, and track patient risk.
The company’s AI-driven software platform has a proven, measurable impact on surgical efficiency and outcomes, reducing patient complications, OR downtime, and unneeded costs to health systems.
Company : Caresyntax
Investment type : Growth Equity
Investment date : January 2021
Location : Berlin, Germany
Website : caresyntax.com
surgeries per minute
are added to the platform
involved on the platform
“What attracted us to Caresyntax, beyond its visionary co-founders and sharp commercial and R&D teams, was the company’s ‘win-win-win’ formula that improves patient safety, delights surgeon users, and reduces costs for the entire system.”
Alex Slack, Founding Partner at Lauxera